Sofosbuvir / Velpatasvir Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: Sofosbuvir 400 mg + Velpatasvir 100 mg
Reference Brands: Epclusa (EU & US), Velpanat (india)
Category: Hepatitis
Sofosbuvir 400 mg + Velpatasvir 100 mg Tablets (Epclusa® generic) are used to treat all major HCV genotypes. Manufactured under EU-GMP/USFDA compliance, ideal for B2B supply, tenders, and licensing with full CTD and regulatory support.
Product Description:
Sofosbuvir 400 mg + Velpatasvir 100 mg tablets (Epclusa® generic) are oral antivirals indicated for pan-genotypic Hepatitis C treatment. This once-daily fixed-dose combination is effective across all major HCV genotypes and offers high SVR rates. Manufactured under EU-GMP and USFDA-approved facilities, the product is available for B2B supply, tenders, and contract manufacturing. Regulatory support includes CTD dossiers and bioequivalence studies. Widely accepted across EU, US, LATAM, and MENA markets, Sofosbuvir + Velpatasvir is a key addition to antiviral portfolios targeting global Hepatitis C elimination goals.
Sofosbuvir / Velpatasvir — third party manufacturing & bulk supply
Sofosbuvir / Velpatasvir is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Sofosbuvir / Velpatasvir is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Sofosbuvir / Velpatasvir listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Sofosbuvir / Velpatasvir →Frequently Asked Questions
Sofosbuvir / Velpatasvir is used for the treatment of chronic hepatitis C virus (HCV) infection across all major genotypes (1 to 6). It helps reduce viral load and can achieve sustained virologic response (SVR), effectively curing the infection in most patients.
Sofosbuvir is a nucleotide analog NS5B polymerase inhibitor, and Velpatasvir is an NS5A inhibitor. Together, they work by blocking different stages of the hepatitis C virus replication process.
The primary trade name is Epclusa, along with multiple generic brands such as Velpanat, Myhep All, SoviHep V, and Sofosvel available in different regions.
The innovator product Epclusa is manufactured by Gilead Sciences, while several generic pharmaceutical companies such as Zydus Lifesciences, Mylan, and Hetero Drugs manufacture and supply this combination globally.
The generic name is Sofosbuvir 400 mg + Velpatasvir 100 mg.
Brand names include Epclusa, Velpanat, Myhep All, SoviHep V, and Sofosvel.
It is manufactured in multiple countries including the United States (by Gilead Sciences) and widely in India by leading pharmaceutical companies for global export markets.
Related Products
Eltrombopag 12.5 Mg Tablet
Strength:
Tablet: 25 mg, 50 mg, 75 mg; Suspension: 12.5 mg/5 mL
Form: Tablets & Oral suspension
Reference Brands: Promacta® (US & EU); Revolade®(EU)
View Details
Thymosin Alpha 1
Strength:
1.6 mg/vial
Form: Lyophilized Powder for Injection
Reference Brands: Zadaxin® (EU & US)
View Details
Sofosbuvir
Strength:
400 mg
Form: Film-coated Tablets
Reference Brands: Sovaldi® (EU & US)
View Details
Eltrombopag Solution
Strength:
12.5 mg, 25mg
Form: Oral Solution
Reference Brands: Promacta (USA)
View DetailsLamivudine Zidovudine & Nevirapine Tablets
Strength:
150mg + 300mg + 200mg
Form: Tablets
Reference Brands: Duovir-N (India)
View DetailsLamivudine Stavudine & Nevirapine Tablets
Strength:
150mg + 40mg + 200mg
Form: Tablets
Reference Brands: Triomune (India)
View DetailsQuick Response Guaranteed | Verified Suppliers
